Fico, Annalisa <br/><br/>
Reducing glypican-4 in ES cells improves recovery in a rat model of Parkinson's disease by increasing the production of dopaminergic neurons and decreasing teratoma formation.  [electronic resource] 

 -  The Journal of neuroscience : the official journal of the Society for Neuroscience  Jun 2014 
 - 8318-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1529-2401 
<br/><br/><label>Standard No.: </label>10.1523/JNEUROSCI.2501-13.2014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Calbindins--metabolism<br/>Cell Count<br/>Cell Differentiation<br/>Disease Models, Animal<br/>Dopamine Plasma Membrane Transport Proteins--metabolism<br/>Dopaminergic Neurons--physiology<br/>Embryonic Stem Cells--transplantation<br/>Glypicans--genetics<br/>Green Fluorescent Proteins--genetics<br/>Hepatocyte Nuclear Factor 3-beta--metabolism<br/>Humans<br/>Mice<br/>Motor Activity--drug effects<br/>Parkinson Disease--physiopathology<br/>Rats<br/>Receptors, Dopamine D2--metabolism<br/>Recovery of Function--physiology<br/>Teratoma--etiology<br/>Tyrosine 3-Monooxygenase--metabolism